Many studies have reported associations between air pollution particles with an aerodynamic diameter <2.5 m (fine particulate matter (PM)) and adverse cardiovascular effects. However, there is an increased concern that so-called ultrafine PM which comprises the smallest fraction of fine PM (aerodynamic diameter <0.1 m) may be disproportionately toxic relative to the 0.1-2.5 m fraction. Ultrafine PM is not routinely measured in state monitoring networks and is not homogenously dispersed throughout an airshed but rather located in hot spots such as near combustion sources (e.g., roads), making it difficult for epidemiology studies to associate exposure to ultrafine PM with adverse health effects. Thirty four middle-aged individuals with metabolic syndrome were exposed for 2 h while at rest in a randomized crossover design to clean air and concentrated ambient ultrafine particles (UCAPS) for 2 h. To further define potential risk, study individuals carrying the null allele for GSTM1 (a prominent antioxidant gene) were identified by genotyping. Blood was obtained immediately prior to exposure, and at 1 and 20 h afterward. Continuous Holter monitoring began immediately prior to exposure and continued for 24 h. Based on changes we observed in previous CAPS studies, we hypothesized that ultrafine CAPS would cause changes in markers of blood inflammation and fibrinolysis as well as changes in heart rate variability and cardiac repolarization. GSTM1 null individuals had altered cardiac repolarization as seen by a change in QRS complexity following exposure to UCAPS and both the entire study population as well as GSTM1 null individuals had increased QT duration. Blood plasminogen and thrombomodulin were decreased in the whole population following UCAPS exposure, whereas C-reactive Disclaimer: The research described in this article has been reviewed by the Environmental Protection Agency and approved for publication. The contents of this article do not necessarily represent agency policy nor does mention of trade names or commercial products constitute endorsement or recommendation for use.
Numerous epidemiology studies have shown that exposure to ambient airborne particulate matter (PM) is associated with increased mortality and morbidity, especially in elderly people with cardiovascular disease (EPA, 2009) . Ambient PM is a complex mixture of organic and inorganic compounds adsorbed onto a carbonaceous core. Its composition varies across time and space and depends on factors such as primary sources (e.g., traffic and power plant emissions, biomass burning, crustal, or biological material), and meteorological and geographical conditions that are specific to the area in which it is sampled. For regulatory purposes, PM is divided into two size fractions based on the aerodynamic diameter of the particles. Coarse PM (particles with a diameter between 2.5 and 10 m) is mainly derived from resuspended crustal materials, sea salt, biological matter, and suspended material derived from surface wear such as those that occur with automobile tires and brakes. Fine PM (particles with a diameter <2.5 m) is primarily derived from combustion sources and may contain both primary emissions as well as secondary particles formed by atmospheric chemistry processes as primary particles "age." The smallest fine PM component consists of ultrafine PM (particles with a diameter <0.1 m) and is primarily derived from direct emissions from combustion sources such as motor vehicles and associated photochemical ultrafine emissions from organic vapors. Ultafine particles are unstable and grow through coagulation or condensation within a few hours to form larger aggregates in the fine PM range. Al-62 DEVLIN ET AL. though ultrafine PM mass is small (5-10% of PM 2.5 mass), this size class dominates particle number and surface area.
Because fine PM is relatively homogenously distributed throughout an airshed and there are extensive monitoring networks in place for its measurement, most epidemiology studies have focused on this size class when reporting associations between PM and adverse health effects. However, nearly all these studies link PM mass with adverse health effects and therefore may not adequately assess effects of ultrafine PM, which has very little mass but a very large surface area. There is concern that ultrafine PM may have the potential to cause adverse health effects because these very small particles are deposited more efficiently throughout the respiratory tract (Kim and Jaques, 2000) , are cleared more slowly than larger particles (Choi and Kim, 2007) , cause oxidative stress (Araujo, 2010; Li et al., 2003) , and have been proposed to readily exit the lung and enter the circulatory system where they could impact other tissues or organs (Nemmar et al., 2002) . There have been only a handful of epidemiology panel studies that have assessed potential adverse health effects caused by ultrafine PM (Chan et al., 2004; Leitte et al., 2012; Ruckerl et al., 2006; Stolzel et al., 2007) because, in contrast to fine PM, these particles are usually located in "hot spots" (e.g., near busy roads) and there are no extensive monitoring networks in place to measure this size range. Consequently, studies that use personal monitoring or in which participants either reside or are taken to environments rich in ultrafine PM have been primarily used to assess potential health effects of these ultrafine PM. Some of these studies have observed positive associations between emissions from roads and changes in cardiovascular endpoints (Delfino et al., 2008 (Delfino et al., , 2010 (Delfino et al., , 2011 Peters et al., 2004; Timonen et al., 2005) , but it is difficult to determine with certainty whether observed effects are due to ultrafine PM, other environmental agents associated with traffic such as gases and organic vapors, or even nonenvironmental factors associated with busy roads such as stress or noise.
Devices capable of concentrating different PM size classes without concentrating gases or organic vapors (Gupta et al., 2004; make it possible to perform controlled exposure studies in which human volunteers are exposed to concentrated ultrafine particles (UCAPS). Two such studies have been reported. Relative to control exposures to clean air, healthy young volunteers exposed to UCAPS for 2 h experienced mild pulmonary inflammation (increased IL-8 in bronchoalveolar lavage fluid), increased vascular d-dimer (fibrin degradation product), changes in autonomic nervous system control of heart rate (increased high frequency and low frequency power), and a decrease in QTc duration (Samet et al., 2009) . In another study, adult volunteers (healthy or with mild asthma) exposed to UCAPS for 2 h experienced a small drop in arterial saturation, a small drop in forced expired volume in 1 s (FEV1), and a decrease in low frequency power (Gong et al., 2008) . In addition to these studies of concentrated ambient air particles, a number of controlled exposure studies have been published in which humans were exposed to diesel exhaust, which is near ultrafine in range, though likely of different chemical composition because it is derived from a single source (see review by Ghio et al., 2012) . These studies have reported numerous changes including increased vascular and stiffness, altered vasomotor function, and upregulation of thrombotic mechanisms.
Epidemiology studies indicate that people with cardiovascular disease are the primary targets of PM and people with diabetes have been shown to be especially susceptible (Zanobetti and Schwartz, 2001) . Recent panel studies have reported PMassociated changes in endothelial cell dysfunction, blood inflammation, and autonomic nervous system control of heart rate in diabetics Schneider et al., 2008) . Metabolic syndrome (MeS) is a term that describes a group of risk factors that increase the likelihood of developing cardiovascular disease (Grundy, 2008; Suzuki et al., 2008) and can lead to the development of diabetes. This syndrome affects as much as 30% of the U.S. population (Ford, 2004) . Risk factors include central obesity, dyslipidemia (elevated triglycerides and low density lipoprotein), decreased high density lipoprotein, high blood pressure, and insulin resistance. Insulin resistance is a good indicator of progression to overt diabetes (Weiss, 2005) and studies in animals have shown that chronic air pollution exposure can increase insulin resistance (Rajagopalan and Brook, 2012) . Therefore, people with MeS represent a large group of the population who may be especially responsive to air pollutants.
Genetic factors have also been shown to play a role in responsiveness to air pollutants, especially genes involved in oxidative stress pathways, such as the glutathione-s-transferase M1 (GSTM1) gene. An association was reported between PM concentration and decreased heart rate variability in individuals with the null GSTM1 allele, which is present in about 40% of the population, but not in people with that gene present . An association was also reported between PM concentration and endothelial cell dysfunction in diabetics with the null GSTM1 allele but not in people with the active gene (Schneider et al., 2008) . PM concentrations were associated with insulin resistance indices in a group of elderly Koreans, and the associations were stronger among participants carrying the null GSTM1 allele (Kim and Hong, 2012) . In this study, we assessed cardiopulmonary responses in a group of individuals with MeS but no overt cardiovascular disease or diabetes who were genotyped for the GSTM1 polymorphism and exposed to clean air and concentrated ambient ultrafine particles.
MATERIALS AND METHODS
Study design and exposure. In a randomized crossover study, 34 participants were exposed twice while at rest for a 2-h period: once to clean air and once to concentrated ambient ultrafine particles. The sequence of the exposures was randomized and both participants and investigators were blinded as to the exposure order. Each exposure was separated by at least 2 weeks and all exposures were conducted at the same time of day to avoid confounding by circadian variations. In addition, participants were asked to take any allowed medications at the same time of day prior to both the air and CAPS exposures. Diet on the day of exposure was not controlled. The exposures were conducted at the EPA Human Studies Facility on the campus of the University of North Carolina and the exposure chamber and concentrator have been described previously (Samet et al., 2009) . Ambient particles were concentrated from Chapel Hill air and the concentrated particles passed through a size-selective outlet that removed most particles with an aerodynamic diameter >0.16 m. Particle mass was measured continuously using a ThermoFisher Scientific DataRam 4 (Franklin, MA), particle number measured continuously using a TSI 3022A condensation particle counter (CPC), and particle size distribution measured using a TSI 3936L22 Scanning Mobility Particle Sizer (SMPS) (Shoreview, MN).
Measurements. The main outcomes of this study were chosen based on significant findings that were observed in previous controlled exposure CAPS studies done in this facility, particularly studies in which participants were exposed to concentrated ultrafine particles (Samet et al., 2009) . We expected to see changes in markers of the fibrinolysis pathway, alterations in blood lipids, changes in frequency domain markers of HRV indicative of change in vagal input, and markers of repolarization. Other endpoints examined in this study are exploratory in nature.
As described previously (Schneider et al., 2008) , brachial artery diameter (BAD), endothelium-dependent flow-mediated dilatation (FMD), and nitric oxide-mediated dilatation (NMD) were measured by ultrasound of the brachial artery in the University of North Carolina Hospitals Clinical Translational Research Center (CTRC) using a 12.5-MHz imaging probe interfaced with an ATL HDI 5000 ultrasound machine with an axial resolution of 0.7 mm. It was a 5-min walk from the exposure facility to the CTRC or a few minute drive in the inclement weather. After the subject rested for 15 min in a supine position, baseline images of the right brachial artery (BAD1) were captured at end-diastole. Hyperemia was induced by inflating a pneumatic tourniquet proximal to the brachial artery to 50 mm Hg above systolic pressure for 5 min. Images of the brachial artery were acquired for 90 s after abrupt cuff deflation. A second baseline image was acquired after 15 min of rest (BAD2), and a final image was then recorded 5 min after administration of 400 g sublingual nitroglycerin spray. Arterial diameter was measured off-line from the lumen-intimal interfaces of the proximal and distal walls using customized software (Brachial Tools, Medical Imaging Applications, LLC, Coralville, IA). The changes in BAD after each exposure were calculated as the difference between post-and pre-exposure measurements. Flow mediated dilitation (FMD) and nitroglycerin mediated dilation (NMD) were calculated as the maximal percentage changes in diameter resulting from reactive hyperemia or nitroglycerin administration, respectively. FMD is a measure of endothelialdependent vasomotion and is due largely to endothelial release of NO, whereas the endothelium-independent dilitation observed in response to nitroglycerin reflects vascular reactivity to an exogenous NO donor. Ultrasound examinations were performed immediately before, 1 h after, and 20 h after each exposure.
Blood pressure was measured in the right arm following 15 min of supine rest before and 1 h after clean air and UCAPS exposure using an automated oscillometric BP monitor (Omron Healthcare, Inc., Vernon Hills, IL). In addition, BP was also measured at 15-min intervals during the 2 h exposure sessions using an automated BP monitor (Spacelabs, Redmond, WA).
Venous blood was sampled from an antecubital site immediately before, 1 h after, and 20 h after each exposure. A differential blood count and blood lipid panel were performed by LabCorp (Burlington, NC). Commercially available ELISA kits were used to quantify levels of C-reactive protein (CRP), serum amyloid A (SAA), sICAM, thrombomodulin, E-selectin, and Pselectin (Mesoscale Discovery, Rockville, MD); d-dimer and von Willebrand's factor (Diagnostica Stago, Parsippany, NY); tissue plasminogen activator (tPA) and plasminogen (Enzyme Research Laboratories, South Bend, IN); and plasminogen activator inhibitor 1 (PAI-1) (DakoCytomation, Carpenteria, CA). Due to technical difficulties thrombomodulin, E-selectin and Pselectin were only performed on 19 participants.
Continuous ambulatory electrocardiograms (Holter ECGs) were collected for ∼24 h using a Mortara H12+ 12-Lead ECG Recorder (Mortara Instrument Co., Milwaukee, WI) as described earlier (Tong et al., 2012) . The digitally recorded ECGs were sampled at 1000 Hz and a trained research nurse blinded to the exposure randomization manually edited the sequence of ECG complexes to ensure proper labeling of each QRS complex. Time-domain parameters (SDNN, PNN 50 ) were calculated over a 24-h period starting just prior to each exposure. Frequency-domain parameters were measured during three 30-min periods (immediately prior to exposure and ∼1 h and 20 h after the completion of exposure) while the subjects rested quietly in a darkened room. The final 5 min of recording during these resting periods were used for calculation of frequency domain and repolarization variables. High frequency (HF, 0.15-0.4 Hz) and low frequency (LF, 0.04-0.15 Hz) were calculated in millisecond. Premature atrial contractions (PAC) and premature ventricular contractions (PVC) were calculated over the entire 24-h monitoring period. The effects on cardiac repolarization were assessed by measuring the QT interval corrected for heart rate (QTc). QTc was calculated from the raw Holter ECG data using proprietary analysis software from Mortara, Inc., which corrects for heart rate by using a subject-specific QT/RR slope. The complexity of the QRS complex was also calculated using Mortara software and is defined as the ratio of the second eigenvalue to the first. Due to technical difficulties, Holter measurements were only performed on 19 participants.
Statistical analysis. All endpoints measured 1 h (post) and 20 h (followup) following exposure were divided by preexposure values and expressed as percentage of the baseline (pre-exposure), with the exception of the 24 h Holter time domain data. Normalization against pre-exposure values is regularly performed in controlled-exposure studies to account for day to day variability of baseline levels in subjects. By normalizing against pre-exposure values and comparing each person's response to air exposure with the same person's response to UCAPS exposure, a number of other confounding parameters are also controlled (e.g., age, gender, medication use, diurnal variation, etc.). The post/pre and followup/pre values after both air and UCAPS exposure were used to calculate statistical significance. Linear mixed effects models were used to test changes in the relative biological endpoints between UCAPS and clean air exposures. Random intercept models account for the individual baseline values and allow distinction of withinfrom between-subject variability. However, this method also assumes there is a linear dose-response CAPS which has not been shown to be true. Changes between normalized endpoints following UCAPS compared with clean air exposure are shown per 10 5 particles/cm 3 increase in UCAPS concentration or per 100 g/m 3 increase in UCAPS mass along with associated 95% two-sided confidence intervals. Changes are expressed as percentage point changes relative to baseline (pre-exposure) values. R statistical software (version 2.3.1) was used for the analyses. Alpha of 0.05 was used to determine statistical significance. Because of the number of endpoints measured in this study it is possible that some changes were due to chance alone.
RESULTS

Study Subjects
Thirty four participants, 13 male and 21 female, with MeS completed the study. The average age of the participants was 47.8 with a range of 27-70 years. To be enrolled in the study, participants had to meet three of the following five criteria: abdominal obesity as measured by waist circumference >40 in. for men or 35 in. for women; triglycerides >150 mg/dl; HDL cholesterol <40 mg/dl for men and 50 mg/dl for women; fasting blood glucose >100 mg/dl; and blood pressure >130/85 mm Hg or a physician diagnosis of hypertension treated with medication. Participant characteristics are shown in Table 1 . Participants were free of cardiopulmonary disease and allergies as determined by a detailed medical history and physical examination and were nonsmokers by self-description. Participants were informed of the procedures and potential risks and signed an informed consent. The protocol and consent forms were approved by the University of North Carolina School of Medicine Committee on the Protection of the Rights of Human Subjects and the U.S. Environmental Protection Agency. Previous studies have shown that individuals carrying the null allele of the GSTM1 gene, a member of the phase 2 antioxidant defense fam- ily, are more responsive to air pollutants than those carrying the wild-type allele. Therefore, each participant was genotyped to determine which allele of this gene they carried.
UCAPS Exposure
Analysis of the UCAPS size distribution in this study with an SMPS showed that particles with diameter <0.025 m made up 11% of the population, those with a diameter <0.050 m made up 37% of the population, those with a diameter <0.075 m made up 58% of the population and those with a diameter <0.10 m (a widely agreed upon cutoff for calling a particle an ultrafine particle) made up 73% of the particles. More than 95% of the particles had a diameter of <0.25 m. Particle concentrations inside the exposure chamber were dependent on ambient concentrations that day and the average concentration factor was 23.9 ± 2.9. The average particle concentration in the chamber was 189,000 particles/cm 3 , with a range of 16,000-564,000; the average particle mass in the chamber was 98 g/m 3 with a range of 15-366 g/m 3 . There was little correlation between particle number and mass on a given day as shown in Figure 1 (R 2 = 0.02). This presents an opportunity to determine whether biological changes are more closely associated with particle number, which is enriched in smaller particles; or with particle mass, which is enriched in larger particles, typically those >0.1 m in diameter (Fig. 2) .
Exposure to UCAPS does not Cause Changes in Brachial
Artery Diameter or Blood Pressure UCAPS-induced changes in BAD, FMD, and blood pressure are shown in Table 2 . As expected, induction of reactive hyperemia resulted in a 0.34 ± 0.06 mm increase in BAD. However there was no difference in response between air and UCAPS exposures. There was a trend (p = 0.085) for decreased BAD measured prior to induction of reactive hyperemia (BAD1) 1 h after exposure to UCAPS (as measured by particle mass) in GSTM1 null individuals. As shown in Table 2 , in those individuals carrying the GSTM1 null allele (GSTM1−), immediately after exposure to UCAPS the brachial artery failed to return to its baseline diameter 15 min following reactive hyperemia (BAD2) as measured by particle number (p = 0.048) and mass (p = 0.003).
Neither we nor others have observed this change before and it is not clear how to interpret it. It could have occurred due to chance associated with multiple testing. There were no UCAPSinduced changes in BAD following administration of nitroglycerin (NMD). There was no change in blood pressure immediately following UCAPS exposure or the next morning. Blood pressure was also measured every 15 min while the participants were being exposed to air or UCAPS and, as shown in Figure 2 , there were no UCAPS-induced changes in either systolic or diastolic blood pressure.
Exposure to UCAPS Causes Changes in Cardiac
Repolarization and Heart Rate Variability UCAPS-induced changes in both time and frequency domain HRV as well as markers of cardiac repolarization were measured and are shown in Table 3 (only changes related to particle number are shown). As shown in Figure 3 , there was a small but statistically significant increase in the duration of the corrected QT interval associated with UCAPS particle number 1 h after exposure in GSTM1 null individuals (p = 0.007); there was also a nonsignificant trend for an increase in QTc in the entire study population 1 h after exposure (p = 0.085). Increased QT duration has been associated with a risk of developing ven- tricular arrhythmias. QRS complexity was increased at both 1 h (p = 0.025) and 20 h (p = 0.008) after exposure in GSTM1 null individuals. Complexity of the QRS wave is a measure of the spread of depolarization through the ventricular muscle. There was also an increase in QTc associated with particle mass in the entire study population 20 h after UCAPS exposure (p = 0.032) (Supplementary table 1) . Table 3 and Figure 4 show that 1 h after exposure the GSTM1 null subpopulation had UCAPS-induced decrease in the high frequency component normalized to heart rate (HFn) (p = 0.042) as well as an increase in the ratio of low frequency to high frequency (LF/HF) (p = 0.030). There was also an increase in LFn 1 h after UCAPS exposure (p = 0.034). No HRV changes were associated with particle mass. 
Exposure to UCAPS Causes Changes in Vascular Markers of Inflammation and Fibrinolysis
Vascular markers associated with fibrin formation, fibrinolysis, cell adhesion, and inflammation were measured and percentage changes following UCAPS exposure are shown in Table 4. With one exception, only associations with particle number, not particle mass, were observed. As shown in Figure 5 , two proteins associated with the acute phase response, CRP and SAA, were increased by UCAPS in the whole study population but not when the GSTM1-subpopulation was analyzed sepa- rately. CRP, whose levels rise in response to vascular inflammation, was increased 30.4% 20 h after exposure (p = 0.016). SAA, which is secreted during the acute phase of inflammation, was increased 77.5% per 100,000 particles/cm 3 20 h after exposure (p = 0.043). In addition two proteins involved in the fibrinolytic pathway were decreased by UCAPS in the whole study population. Plasminogen, a precursor of plasmin which dissolves fibrin blood clots, was decreased 13.8% 20 h after UCAPS exposure (p = 0.022). Thrombomodulin, a protein expressed on the surface of vascular endothelial cells which converts thrombin from a procoagulant to an anticoagulant enzyme, was decreased 1.8% 20 h after UCAPS exposure (p = 0.048). GSTM1-individuals were not more responsive than the entire study population for measured soluble blood proteins with one exception. GSTM1-individuals had 5.6% decrease in P-selectin 1 h after exposure whereas there was no change in the entire study population (p = 0.023). The only UCAPS-induced change associated with particle mass was a 4.8% decrease in E-selectin 20 h after exposure in the total population (p = 0.41) (Supplementary table 2) . These two selectins are found on endothelial cells and play an essential role in recruiting neutrophils to the site of injury during inflammation.
Levels of blood cells (neutrophils, lymphocytes, monocytes, platelets) and blood lipids were also measured. There were no UCAPS-induced changes in any of these parameters (data not shown).
DISCUSSION
Several recent epidemiological panel studies have reported biological changes associated with acute exposure to environments that are enriched in ultrafine particles (e.g., near busy roads). However, these studies have difficulty determining whether the observed changes were caused by ultrafine particles or other pollutants found near roads or even factors such as stress associated with driving in heavy traffic. In this study, we used a device capable of concentrating ultrafine particles without concentrating larger particles (fine or coarse PM), pollutant gases or organic vapors to expose volunteers to both clean air and UCAPS. This allowed us to directly measure cardiovascular changes caused by exposure to ultrafine particles. Two previous studies (Gong et al., 2008; Samet et al., 2009 ) have used similar concentrators to expose healthy young volunteers to UCAPS, but this is the first study in which a potentially susceptible population, those with metabolic syndrome, have been exposed to UCAPS.
The vascular endothelium has a number of functions, including maintaining vascular homeostasis, the dynamic bal- ance between vasodilation and vasoconstriction. Endothelial dysfunction is typically characterized by the loss of normal endothelium-dependent vasodilation (Mahmoudi et al., 2007) , is associated with many known cardiovascular risk factors, and is an excellent measure of underlying vascular health. Endothelial cells mediate vasodilation primarily through the production of NO, which diffuses into the underlying smooth muscle cells where it is responsible for smooth muscle cell relaxation and vasodilation. We have previously shown associations between acute changes in ambient PM 2.5 levels and FMD, an index of endothelial cell function, in a group of GSTM1-diabetics (Schneider et al., 2008) . Others have reported diesel exhaust-induced reduction in BAD in humans as well as reduced bilateral forearm blood flow in response to acetylcholine or bradykinin (Mills et al., 2005; Tornqvist et al., 2007) . However, we did not observe changes in either FMD or initial BAD in this study. This finding is in contrast to observations from several studies in which human volunteers were exposed to diesel exhaust. These studies reported negative effects on vasomotor function as measured by diesel exhaust attenuation of forearm blood flow induced by bradykinin, acetylcholine, and nitroprusside infusion (reviewed in Ghio et al., 2012) .
We did not observe changes in blood pressure in this study either during the 2-h exposure period or after the exposure was completed. This is in contrast with some studies which reported increased diastolic but not systolic blood pressure following a 2-h exposure of healthy participants to fine CAPs + ozone (Urch et al., 2005) ; increased systolic but not diastolic blood pressure following exposure of healthy participants to fine or coarse CAPs (Bellavia et al., 2013) ; and an increase in systolic blood pressure during and after exposure of healthy participants to 200 g/m 3 diesel exhaust (Cosselman et al., 2012) . However, our findings are consistent with studies which observed no change in blood pressure in healthy individuals exposed to 300 g/m 3 diesel exhaust (Langrish et al., 2009; Lundback et al., 2009) or ultrafine carbon particles (Shah et al., 2008) .
We observed a 0.8% increase in the corrected QT interval 1 h after UCAPS exposure in the GSTM1 null group. This increase is consistent with what we have reported earlier in young healthy individuals exposed to ozone . Although this is a small increase, there may be clinical implications worth noting. In this study the average QT interval was 421 ms. The 0.8% increase corresponds to a 3.4 ms lengthening of the QT interval. To put this small change in context, any drug which prolongs the QT interval by >5 ms raises the possibility of proarrhythmic risk (FDA, 2005) . There was also a significant an increase in QRS complexity in the GSTM1-subpopulation 1 h after exposure, and which was still significantly elevated 20 h after exposure.
Altered cardiac autonomic nervous system control of heart rate (HRV) is considered to be one of the pathophysiological mechanisms by which PM affects the cardiovascular system (Pope and Dockery, 2006) . Numerous epidemiology studies have reported a PM-associated decrease in the high frequency component of HRV (Holguin et al., 2003; Liao et al., 1999; Pope et al., 1999) in elderly people, and some have found that decreased HF is more pronounced in people with the GSTM1 null allele (Chahine et al., 2007) . HF power has been used as a marker of parasympathetic modulation of heart rate, LF power a marker of sympathetic modulation of heart rate, and the ratio of LF/HF power has been used as an index of "sympatho-vagal balance." In this study, we observed a decrease in HF power, which agreed with an earlier study in which we reported decreased HF power in elderly participants were exposed to fine CAPS (Devlin et al., 2000) . In contrast, we reported increased HRV in young healthy people exposed to UCAPS (Samet et al., 2009) and no changes in young healthy people exposed to fine CAPS (Devlin et al., 2000) , suggesting that PM-induced decreases in autonomic nervous system control of heart rate may be more pronounced in older people.
We observed UCAPS-induced increases in CRP and serum amyloid alpha, two markers associated with vascular inflammation and acute phase response, in the entire study population 20 h after exposure. We have not seen these proteins increased following exposure of young healthy individuals to ultrafine (Samet et al., 2009) , fine (Ghio et al., 2003) , or coarse ) CAPs, raising the possibility that these changes may be restricted to older individuals or people with risk factors for cardiovascular disease such as those enrolled in this study. We also observed decreases in markers associated with the fibrinolytic pathway in the entire study population 20 h after exposure. These changes could promote an environment in which blood clots are not efficiently dissolved and could potentially place an individual with cardiovascular disease at greater risk for myocardial infarction. It has been suggested that PMinduced changes in vascular tone and cardiac repolarization are neurogenically mediated, which may account for their rapid response within an hour of exposure. In contrast markers of fibrinolysis were elevated 20 h after exposure. Furthermore, changes in vascular tone and cardiac repolarization were only found in people with the GSTM1 null allele, whereas fibrinolytic were observed in the entire study population. These data suggest that UCAPS may alter the fibrinolytic pathway by a different mechanism than that controlling changes in vascular tone or cardiac repolarization. These data are consistent with previous studies in which reported diesel exhaust induced changes in plasma fibrinolytic factors such as tPA as well as increased ex vivo thrombus formation (reviewed by Ghio et al., 2012) .
Epidemiology studies show that people with diabetes are more susceptible to air pollutants than those without diabetes (Zanobetti and Schwartz, 2001) . People with MeS make up as much as 30% of the U.S. population and are at risk for developing diabetes and cardiovascular disease (Ford, 2004) . A small number of epidemiology studies report that long-term exposure to PM is associated with increased vascular inflammation (Chen and Schwartz, 2008) and decreased heart rate variability (Park et al., 2010) in people with MeS. In this study, we show that people with MeS respond acutely to a single exposure to UCAPS with changes in a number of cardiovascular endpoints. We previously published a study in which young healthy volunteers with no risk factors for diabetes or cardiovascular disease were exposed to UCAPS (Samet et al., 2009) . Because the exposure system and geographical location was the same for both studies, as were many of the assays, it is possible to ask whether people with MeS are more responsive to UCAPS than healthy young people. Although those with MeS were exposed on average to moderately higher average particle concentrations than the healthy young participants, the results in both studies were normalized to 100,000 particles/cm 3 or per 100 g/m 3 UCAPS mass. Among the endpoints that were assessed in both studies, the two populations both had UCAPS-induced changes in cardiac repolarization and proteins associated with fibrinolysis. People with MeS also had increased levels of CRP. Both the young and MeS participants had altered frequency domain HRV parameters. However, the magnitude of changes in both studies were comparable and we are unable to conclude from the comparison that those with MeS are overall more responsive to UCAPS than people without those risk factors. Furthermore, many of the changes observed in those with MeS were only found in individuals carrying the GSTM1 null allele, whereas the changes observed in the young healthy participant study were observed in the entire study population, which was not stratified on the basis of GSTM1. These general conclusions are consistent with other reports suggesting that people with MeS exposed acutely to diesel exhaust have minimal cardiovascular responses Krishnan et al., 2013) . Thus, while long term PM exposure to those with MeS may result in enhanced responses compared with non-MeS individuals, this may not be true for acute exposures.
It is widely thought that reactive oxygen species (ROS) play a major role in causing cardiovascular effects associated with PM exposure. Several studies have reported that individuals carrying the null allele for GSTM1, an enzyme that plays a key role in the cellular defense against oxidants, are more responsive to PM (Chahine et al., 2007; Kim and Hong, 2012; Madrigano et al., 2010; Schneider et al., 2008; Schwartz et al., 2005) , ozone (Alexis et al., 2009) , and endotoxin (Dillon et al., 2011) . Indeed in some studies, only individuals carrying the GSTM1 null allele had significant responses associated with pollutant exposure (Chahine et al., 2007; Schneider et al., 2008; Schwartz et al., 2005) . In this study, UCAPS-induced changes in endothelial cell function were observed only in GSTM1 null individuals, not the entire study population. Similarly, UCAPS-induced changes in markers of HRV and cardiac repolarization were only observed in the subpopulation carrying the GSTM1 null allele. In contrast, blood proteins involved in acute phase response, inflammation and the fibrinolytic pathway were observed in the entire study population. These data suggest that PM may affect some biological pathways by oxidative processes in which GSTM1 may play a role, but not others.
Although particle concentrators can selectively concentrate ultrafine particles by inserting a size selective filter downstream from the concentrator, pressure drops across the filter make it necessary to concentrate particles as large as 0.16 m in diameter, somewhat above the 0.1 m diameter cutoff that is typically considered ultrafine. In this study, particles with an aerodynamic diameter of >0.1 m make up only 27% of the particles, but account for 83% of the particle mass. Because particle number and particle mass in the chamber on any given day is not highly correlated (Fig. 1) , this presents an opportunity to assess whether the observed biological changes were more strongly associated with particle number or particle mass. Changes in cardiac parameters and fibrinolysis were primarily associated with particle number. These findings suggest that ultrafine particles, rather than accumulation mode particles, are responsible for most of the effects we observed.
In summary, this is the first report to show that ambient ultrafine particles can cause cardiovascular changes in people with metabolic syndrome. These changes affect neurogenically mediated events such as HRV and cardiac repolarization, as well as blood proteins involved in fibrinolysis. Most changes are restricted to GSTM1 individuals, agreeing with several previous studies that indicate people carrying the null GSTM1 allele are especially responsive to PM. Interestingly, we could not conclude that people with metabolic syndrome are more responsive to an acute PM exposure than young healthy people.
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